-
Citi: Apple Could Benefit From An Athenahealth Acquisition
Thursday, June 15, 2017 - 1:19pm | 623Read More...Apple Inc. (NASDAQ: AAPL) is looking to turn the iPhone into a central repository for the entirety of a person’s health data, according to CNBC. Doing so would be a huge step above the current wellness tracking done by the Health app installed on iPhones and Apple Watches. The app can already...
-
PAREXEL's Investment Day Leaves Citi Energized
Friday, July 1, 2016 - 4:07pm | 275Read More...Citi said PAREXEL International Corporation (NASDAQ: PRXL) is set up nicely for long term, while still offering near-term opportunities. The brokerage said the company on its investor day, made encouraging comments on its near-term views including book-to-bill ratios and seeing very healthy end...
-
Citi Concerned With Near-Term Risks For Cotiviti, Initiates At Neutral
Monday, June 20, 2016 - 2:40pm | 525Read More...Citi started coverage of Cotiviti Holdings Inc (NYSE: COTV) with a Neutral rating and $21 price target, citing near-term risks including client M&A among its relatively concentrated customer base. "Net, we have a favorable view of the company's offerings but with an ETR of ~10%,...
-
UPDATE: Citigroup Initiates Coverage On PRA Health Sciences On Ingredients For Success
Monday, December 8, 2014 - 10:20am | 156Read More...In a report published Monday, Citigroup analyst Garen Sarafian initiated coverage on PRA Health Sciences (NASDAQ: PRAH) with a Neutral rating and $24.00 price target. In the report, Citigroup noted, “We are initiating on PRA Health Sciences with a Neutral rating and a $24 target price. PRAH, a...
